Cite
HARVARD Citation
Sprague, S. et al. (2015). Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease. Clinical investigation. pp. 9-21. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sprague, S. et al. (2015). Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease. Clinical investigation. pp. 9-21. [Online].